WHAT’S NEW(What does this article add)?
The aim of this study was to use a L-Carnitine supplement in critically ill patients. Since in previous studies in cardiovascular patients this supplement had reduced inflammation, we decided to use this supplement due to high inflammation in critically ill patients, which in our study was also Inflammatory factors were significantly reduced and mortality was reduced for 28 days mortality. This study is a starting point for future plans that are currently reviewing and conducting an L-carnitine supplementation plan in Covid 19 patients to reduce infection and inflammation in imam reza hospital.